课题基金 / 基金详情

The significance of endothelial nitric oxide synthase gene polymorphisms as genetic markers of hypertensive disorders

The significance of endothelial nitric oxide synthase gene polymorphisms as genetic markers of hypertensive disorders
内皮一氧化氮合酶基因多态性作为高血压疾病遗传标记的意义
批准号:
12672236
负责人:
YASUJIMA Minoru
金额:
$2.18万
依托单位:
依托单位国家:
日本
项目类别:
Grant-in-Aid for Scientific Research (C)
财政年份:
2000
资助国家:
日本
项目状态:
已结题
起止时间:
2000 至 2002

项目摘要

项目成果

YASUJIMA Minoru的其他基金

相似基金

相关文献

中文摘要
翻译
一氧化氮(NO)在调节血压和局部血流中起着重要作用。NO活性降低可导致肾血管收缩、NaCl滞留和血压升高。内皮NO合成酶(ecNOS)基因已被认为是高血压和肾脏疾病的潜在遗传危险因素。为了确定ecNOS基因多态性作为高血压及其并发症的遗传标记的意义,我们研究了日本受试者中ecNOS基因多态性与高血压的关系。终末期肾病(ESRD)患者和一般地区居民也被纳入本研究。采用限制性内切酶片段长度多态性等PCR方法对ecNOS Glu298Asp和4b/a变异进行基因型分析。此外,还检测了2个ecNOS变异与血管紧张素转换酶I/D多态性和Y染色体Alu插入多态性(YAP)之间的连锁不平衡。高血压与ecNOS Glu298Asp基因多态性呈正相关。然而,ecNOS 4b/a基因多态性与高血压无关。Glu/Glu基因型患者的收缩压明显低于Glu/Asp+Asp/Asp基因型患者。然而,Glu298Asp和4b/a变异均与ESRD(包括慢性肾小球肾炎和糖尿病肾病)无关。ecNOS 4b/ A基因多态性与YAP之间存在显著的连锁不平衡。提示ecNOS Glu298Asp基因多态性可能是高血压的遗传易感因素。
英文摘要
The nitric oxide (NO) plays an important role in the regulation of blood pressure and regional blood flow. Decreased NO activity could contribute to renal vasoconstriction, NaCl retention, and elevated blood pressure. The endothelial NO synthase (ecNOS) gene has been raised as a candidate of genetic risk factor for the development of hypertension and renal diseases. To establish the significance of ecNOS gene polymorphisms as genetic markers of hypertension and its complications, we studied an association between ecNOS gene polymorphisms and hypertension in Japanese subjects. Patients with end-stage renal disease (ESRD) and general regional residents were also enrolled in this study. The genotypes of the ecNOS Glu298Asp and 4b/a variations were determined with PCR based methods including restriction enzyme fragment length polymorphism. In addition, the linkage disequilibrium between 2 ecNOS variations and angiotensin coverting enzyme I/D polymorphism and Y chromosome Alu insertion polymorphism (YAP) was examined. Positive association was found between hypertension and ecNOS Glu298Asp gene polymorphism. However, ecNOS 4b/a gene polymorphism was not associated with hypertension. Systolic blood pressure was significantly lower in the Glu/Glu genotype than in Glu/Asp+Asp/Asp genotypes. Whereas neither Glu298Asp nor 4b/a variations had an association with ESRD including chronic glomerulonephritis and diabetic nephropathy. A significant linkage disequilibrium was found between ecNOS 4b/a gene polymorphism and YAP.These results suggest that the ecNOS Glu298Asp gene polymorphism may be genetic-susceptibility factors for hypertension.
期刊论文(28)
专著(0)
科研奖励(0)
会议论文
Sato T, Yasujima M, et al.: "Reliable differential diagnosis between osteosarcoma and regenerative bone cells in rats through simultaneous analysis of nuclear DNA content and size"Anal Quant Cytol Histol. 22. 327-332 (2000)
Sato T、Yasujima M 等人:“通过同时分析核 DNA 含量和大小,对大鼠骨肉瘤和再生骨细胞进行可靠的鉴别诊断”Anal Quant Cytol Histol。
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
Shoji M, Yasujima M, et al.: "The role of protein kinases in glycoprotein GMP-140 expression on activated human platelets (eds) Endo M, et al."Elsevier Sciences. 5 (2001)
Shoji M、Yasujima M 等人:“蛋白激酶在活化人血小板上糖蛋白 GMP-140 表达中的作用(编辑)Endo M 等人”Elsevier Sciences。
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
Kanazawa M, Yasujima M, et al.: "Combination therapy with an angiotensin-converting enzyme (ACE) inhibitor and a calcium antagonist : beyond the rencprotective effects of ACE inhibitor monotherapy in a spontaneous hypertensive rat with renal ablation"Hype
Kanazawa M、Yasujima M 等人:“血管紧张素转换酶 (ACE) 抑制剂和钙拮抗剂的联合治疗:超越 ACE 抑制剂单一疗法对肾脏消融的自发性高血压大鼠的肾保护作用”
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
Shoji M, Tsutaya S, Shimada J, Kojima K, Kasai T, Yasujima M: "Lack of association between Y chromosome Alu insertion polymorphism and hypertension"Hypertens Res. 25. 1-3 (2002)
Shoji M、Tsutaya S、Shimada J、Kojima K、Kasai T、Yasujima M:“Y 染色体 Alu 插入多态性与高血压之间缺乏关联”Hypertens Res。
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
共 24 条
    Clinical significance of SLC12A3 gene polymorphisms in diabetic nephropathy
    • 批准号:
      19590546
    • 项目类别:
      Grant-in-Aid for Scientific Research (C)
    • 资助金额:
      $2.75万
    • 财政年份:
      2007
    • 负责人:
      YASUJIMA Minoru
    • 依托单位:
    Clinical Significance of Sodium Metabolism-related Gene Polymorphisms in Salt-Sensitive Hypertension
    • 批准号:
      15590477
    • 项目类别:
      Grant-in-Aid for Scientific Research (C)
    • 资助金额:
      $2.18万
    • 财政年份:
      2003
    • 负责人:
      YASUJIMA Minoru
    • 依托单位:
    Pathological Significance of Gene Polymorphisms of the Renin-Angiotensin System in Hypertension.
    • 批准号:
      09672347
    • 项目类别:
      Grant-in-Aid for Scientific Research (C)
    • 资助金额:
      $2.05万
    • 财政年份:
      1997
    • 负责人:
      YASUJIMA Minoru
    • 依托单位:
    Characterization, localization and quantification of neutral metalloendopeptidase, the degradative enzyme for atrial natriuretic peptide
    • 批准号:
      04670511
    • 项目类别:
      Grant-in-Aid for General Scientific Research (C)
    • 资助金额:
      $1.34万
    • 财政年份:
      1992
    • 负责人:
      YASUJIMA Minoru
    • 依托单位:
    国内基金
    海外基金
    HIF-2α-Snail调节环路在肺血管内皮转化过程中的作用机制研究
    • 批准号:
      81870046
    • 项目类别:
      面上项目
    • 资助金额:
      54.0万元
    • 批准年份:
      2018
    • 负责人:
      赖宁
    • 依托单位:
    硫化氢通过核转录因子-kB信号途径调节高血压大鼠血管平滑肌细胞增殖的研究
    • 批准号:
      81070212
    • 项目类别:
      面上项目
    • 资助金额:
      33.0万元
    • 批准年份:
      2010
    • 负责人:
      金红芳
    • 依托单位:
    内源性硫化氢调控高血压血管基质重塑的研究
    • 批准号:
      30801251
    • 项目类别:
      青年科学基金项目
    • 资助金额:
      21.0万元
    • 批准年份:
      2008
    • 负责人:
      金红芳
    • 依托单位: